Corbus Pharmaceuticals Holdings, Inc.

CRBP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$17,198$13,724$17,003$25,007
Short-Term Investments$131,864$7,182$42,194$72,641
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,914$2,640$984$2,557
Total Curr. Assets$152,976$23,546$60,181$100,205
Property Plant & Equip (Net)$2,518$4,036$5,498$7,002
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$385$690$633$524
Total NC Assets$2,903$4,726$6,131$7,526
Other Assets$0$0$0$0
Total Assets$155,879$28,272$66,312$107,730
Liabilities
Payables$4,786$3,179$2,174$1,782
Short-Term Debt$1,606$17,646$4,430$4,998
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,426$11,069$6,036$10,227
Total Curr. Liab.$11,818$31,894$12,640$17,008
LT Debt$1,633$3,239$20,660$21,592
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$44$22$22
Total NC Liab.$1,633$3,283$20,682$21,615
Other Liabilities$0$0$0$0
Cap. Leases$3,239$4,676$5,956$7,093
Total Liabilities$13,451$35,177$33,322$38,622
Equity
Pref Stock$0$0$0$0
Common Stock$1$0$0$13
Retained Earnings-$476,893-$436,684-$392,081-$349,734
AOCI$35-$1-$126-$62
Other Equity$619,285$429,780$425,196$418,892
Total Equity$142,428-$6,905$32,990$69,108
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$155,879$28,272$66,312$107,730
Net Debt-$13,959$7,161$8,087$1,584
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Financial Statements & Key Stats | AlphaPilot